Eisai And Biogen Announce The Traditional Approval For Leqembi
By, Admin1 min read
Share
Eisai And Biogen Announced That The U.S. Food And Drug Administration (Fda) Has Approved The Supplemental Biologics Licence Application (Sbla) For Leqembi
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
